Michael Yee
Stock Analyst at UBS
(3.36)
# 2,372
Out of 5,078 analysts
1357
Total ratings
46.1%
Success rate
2.3%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABBV AbbVie | Maintained: Hold | $275 | $285.19 | -3.57% | 8 | Oct 23, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $175 | $157.19 | +11.33% | 191 | Oct 23, 2026 | |
| RVMD Revolution Medicines | Rated: Buy | $265 | $187.69 | +41.19% | 9 | Oct 22, 2026 | |
| ADRX ADARx Pharmaceuticals | Initiated Coverage: Buy | $35 | $17.68 | +97.96% | 1 | Oct 20, 2026 | |
| COGT Cogent Biosciences | Reiterated: Buy | $60 | $31.31 | +91.63% | 5 | Oct 13, 2026 | |
| AMGN Amgen | Rated: Buy | $430 → $470 | $447.28 | +5.08% | 189 | Oct 9, 2026 | |
| BIIB Biogen | Rated: Buy | $240 → $270 | $253.84 | +6.37% | 173 | Oct 9, 2026 | |
| BMY Bristol-Myers Squibb Company | Reiterated: Buy | $80 | $63.00 | +26.98% | 7 | Oct 9, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $320 | $267.61 | +19.58% | 4 | Oct 9, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $175 | $147.24 | +18.85% | 8 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $27 | $30.42 | -11.24% | 10 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $3.60 | +233.33% | 4 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $120 | $85.78 | +39.89% | 16 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $585 → $615 | $535.17 | +14.92% | 130 | Sep 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $76 | $48.10 | +58.00% | 6 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $41.96 | +42.99% | 16 | Sep 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $33.43 | +64.52% | 1 | Sep 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $81.15 | +60.20% | 8 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $150 | $202.63 | -25.97% | 71 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 | $43.14 | +50.67% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $34 | $18.66 | +82.21% | 18 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,425 | $1,306.69 | +9.05% | 8 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $90 | $50.46 | +78.36% | 6 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $14.91 | +201.81% | 1 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $36.12 | +38.43% | 3 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $7.02 | +541.03% | 22 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.19 | +404.20% | 13 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $18 → $13 | $22.60 | -42.48% | 18 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $20 | $4.82 | +314.94% | 5 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $7 | $4.70 | +48.94% | 10 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.04 | +130.26% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $21.71 | +107.28% | 1 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $50 | $22.82 | +119.11% | 2 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 → $35 | $22.04 | +58.80% | 19 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $1.25 | +540.00% | 4 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $30 → $28 | $24.56 | +14.01% | 5 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 → $55 | $32.12 | +71.23% | 13 | Jan 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $3.5 | $3.81 | n/a | 8 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $6 | $8.24 | n/a | 48 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $18 | $14.14 | n/a | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $8 | $2.09 | n/a | 6 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $1 | $11.57 | n/a | 34 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $65.31 | n/a | 2 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $46 → $10 | $0.6101 | n/a | 4 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $15 | $5.22 | n/a | 19 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $7 | $20.30 | n/a | 8 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $31 | $22,005.00 | n/a | 3 | Dec 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1.5 → $1 | $1.03 | n/a | 3 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $1.05 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $4.05 | n/a | 1 | Jul 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $0.9501 | n/a | 2 | Oct 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2.5 | $0.0001 | n/a | 2 | Oct 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $56.63 | n/a | 59 | Sep 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $20.31 | n/a | 2 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $6.51 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $48.86 | n/a | 1 | Sep 4, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 | $584.79 | n/a | 43 | Feb 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $626 | $819.09 | n/a | 43 | Jan 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $57 | $11.26 | n/a | 9 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $1.39 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $113 | $116.93 | n/a | 9 | Nov 14, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $102.51 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $46.01 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $96.59 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $307.08 | n/a | 1 | Oct 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 | $148.71 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 → $2 | $0.000001 | n/a | 5 | Jun 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $15 | $18.18 | n/a | 2 | Feb 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $193 | $445.28 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $157 | $424.98 | n/a | 1 | Jan 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 | $2.27 | n/a | 2 | Jan 4, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $20 | $4.21 | n/a | 8 | Nov 6, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $58.36 | n/a | 4 | Aug 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 | $5.76 | n/a | 4 | Jun 30, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $125.54 | n/a | 1 | Jun 29, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $0.0008 | n/a | 2 | Mar 20, 2012 |
AbbVie
Oct 23, 2026
Maintained: Hold
Price Target: $275
Current: $285.19
Upside: -3.57%
Gilead Sciences
Oct 23, 2026
Maintained: Buy
Price Target: $175
Current: $157.19
Upside: +11.33%
Revolution Medicines
Oct 22, 2026
Rated: Buy
Price Target: $265
Current: $187.69
Upside: +41.19%
ADARx Pharmaceuticals
Oct 20, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $17.68
Upside: +97.96%
Cogent Biosciences
Oct 13, 2026
Reiterated: Buy
Price Target: $60
Current: $31.31
Upside: +91.63%
Amgen
Oct 9, 2026
Rated: Buy
Price Target: $430 → $470
Current: $447.28
Upside: +5.08%
Biogen
Oct 9, 2026
Rated: Buy
Price Target: $240 → $270
Current: $253.84
Upside: +6.37%
Bristol-Myers Squibb Company
Oct 9, 2026
Reiterated: Buy
Price Target: $80
Current: $63.00
Upside: +26.98%
Johnson & Johnson
Oct 9, 2026
Reiterated: Buy
Price Target: $320
Current: $267.61
Upside: +19.58%
Merck & Co.
Oct 9, 2026
Reiterated: Buy
Price Target: $175
Current: $147.24
Upside: +18.85%
Oct 9, 2026
Reiterated: Hold
Price Target: $27
Current: $30.42
Upside: -11.24%
Sep 30, 2026
Reiterated: Buy
Price Target: $12
Current: $3.60
Upside: +233.33%
Sep 28, 2026
Reiterated: Buy
Price Target: $80 → $120
Current: $85.78
Upside: +39.89%
Sep 28, 2026
Rated: Buy
Price Target: $585 → $615
Current: $535.17
Upside: +14.92%
Sep 22, 2026
Rated: Buy
Price Target: $76
Current: $48.10
Upside: +58.00%
Sep 13, 2026
Reiterated: Buy
Price Target: $60
Current: $41.96
Upside: +42.99%
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $55
Current: $33.43
Upside: +64.52%
Sep 1, 2026
Reiterated: Buy
Price Target: $130
Current: $81.15
Upside: +60.20%
Aug 20, 2026
Reiterated: Hold
Price Target: $45 → $150
Current: $202.63
Upside: -25.97%
Aug 13, 2026
Rated: Buy
Price Target: $65
Current: $43.14
Upside: +50.67%
Aug 7, 2026
Rated: Buy
Price Target: $25 → $34
Current: $18.66
Upside: +82.21%
Aug 5, 2026
Reiterated: Buy
Price Target: $1,425
Current: $1,306.69
Upside: +9.05%
Jul 24, 2026
Reiterated: Buy
Price Target: $60 → $90
Current: $50.46
Upside: +78.36%
Jun 15, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $14.91
Upside: +201.81%
Jun 9, 2026
Reiterated: Buy
Price Target: $50
Current: $36.12
Upside: +38.43%
Jun 2, 2026
Reiterated: Buy
Price Target: $45
Current: $7.02
Upside: +541.03%
May 12, 2026
Reiterated: Buy
Price Target: $6
Current: $1.19
Upside: +404.20%
Mar 17, 2026
Rated: Hold
Price Target: $18 → $13
Current: $22.60
Upside: -42.48%
Mar 5, 2026
Reiterated: Buy
Price Target: $3 → $20
Current: $4.82
Upside: +314.94%
Mar 3, 2026
Reiterated: Hold
Price Target: $10 → $7
Current: $4.70
Upside: +48.94%
Feb 25, 2026
Reiterated: Buy
Price Target: $7
Current: $3.04
Upside: +130.26%
Feb 17, 2026
Initiated Coverage: Buy
Price Target: $45
Current: $21.71
Upside: +107.28%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $45 → $50
Current: $22.82
Upside: +119.11%
Jan 7, 2026
Initiated Coverage: Buy
Price Target: $50 → $35
Current: $22.04
Upside: +58.80%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $1.25
Upside: +540.00%
Jan 6, 2026
Initiated Coverage: Hold
Price Target: $30 → $28
Current: $24.56
Upside: +14.01%
Jan 6, 2026
Initiated Coverage: Buy
Price Target: $45 → $55
Current: $32.12
Upside: +71.23%
Jun 25, 2025
Reiterated: Hold
Price Target: $1.5 → $3.5
Current: $3.81
Upside: n/a
May 27, 2025
Downgraded: Hold
Price Target: $32 → $6
Current: $8.24
Upside: n/a
Mar 13, 2025
Reiterated: Buy
Price Target: $24 → $18
Current: $14.14
Upside: n/a
Mar 6, 2025
Reiterated: Buy
Price Target: $145 → $8
Current: $2.09
Upside: n/a
Oct 25, 2023
Downgraded: Hold
Price Target: $3 → $1
Current: $11.57
Upside: n/a
Mar 22, 2023
Reiterated: Buy
Price Target: $26
Current: $65.31
Upside: n/a
Dec 22, 2021
Downgraded: Hold
Price Target: $46 → $10
Current: $0.6101
Upside: n/a
Aug 10, 2021
Reiterated: Hold
Price Target: $45 → $15
Current: $5.22
Upside: n/a
Dec 21, 2020
Reiterated: Hold
Price Target: $10 → $7
Current: $20.30
Upside: n/a
Dec 21, 2018
Reiterated: Buy
Price Target: $40 → $31
Current: $22,005.00
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $1.5 → $1
Current: $1.03
Upside: n/a
Jul 8, 2018
Reiterated: Hold
Price Target: $3.5
Current: $1.05
Upside: n/a
Jul 8, 2018
Reiterated: Buy
Price Target: $22
Current: $4.05
Upside: n/a
Oct 27, 2017
Reiterated: Buy
Price Target: $47
Current: $0.9501
Upside: n/a
Oct 2, 2017
Reiterated: Hold
Price Target: $2.5
Current: $0.0001
Upside: n/a
Sep 25, 2017
Reiterated: Buy
Price Target: $116
Current: $56.63
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $47
Current: $20.31
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $7
Current: $6.51
Upside: n/a
Sep 4, 2017
Reiterated: Buy
Price Target: $5
Current: $48.86
Upside: n/a
Feb 23, 2017
Reiterated: Hold
Price Target: $110
Current: $584.79
Upside: n/a
Jan 3, 2017
Reiterated: Buy
Price Target: $626
Current: $819.09
Upside: n/a
Dec 30, 2016
Reiterated: Hold
Price Target: $57
Current: $11.26
Upside: n/a
Dec 20, 2016
Reiterated: Buy
Price Target: $25
Current: $1.39
Upside: n/a
Nov 14, 2016
Reiterated: Buy
Price Target: $113
Current: $116.93
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $48
Current: $102.51
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $28
Current: $46.01
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $95
Current: $96.59
Upside: n/a
Oct 2, 2016
Reiterated: Buy
Price Target: $129
Current: $307.08
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $115
Current: $148.71
Upside: n/a
Jun 15, 2016
Downgraded: Hold
Price Target: $12 → $2
Current: $0.000001
Upside: n/a
Feb 5, 2016
Reiterated: Hold
Price Target: $15
Current: $18.18
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $193
Current: $445.28
Upside: n/a
Jan 25, 2016
Reiterated: Buy
Price Target: $157
Current: $424.98
Upside: n/a
Jan 4, 2016
Reiterated: Hold
Price Target: $7
Current: $2.27
Upside: n/a
Nov 6, 2015
Reiterated: Buy
Price Target: $35 → $20
Current: $4.21
Upside: n/a
Aug 5, 2015
Reiterated: Hold
Price Target: $9
Current: $58.36
Upside: n/a
Jun 30, 2014
Rated: Hold
Price Target: $40
Current: $5.76
Upside: n/a
Jun 29, 2012
Upgraded: Buy
Price Target: n/a
Current: $125.54
Upside: n/a
Mar 20, 2012
Reiterated: Buy
Price Target: $28
Current: $0.0008
Upside: n/a